NASDAQ:MGLN

Magellan Health (MGLN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$94.99
$94.99
50-Day Range
$94.25
$94.99
52-Week Range
$91.04
$99.36
Volume
N/A
Average Volume
238,670 shs
Market Capitalization
$2.50 billion
P/E Ratio
8.28
Dividend Yield
N/A
Price Target
N/A
MGLN stock logo

About Magellan Health Stock (NASDAQ:MGLN)

Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment includes the Behavioral & Specialty Health reporting unit, which provides carve-out management services for behavioral health, employee assistance plans, and other areas of specialty healthcare. The Pharmacy Management segment comprises of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.

MGLN Stock News Headlines

Tech GIANT’s Plans to Revolutionize Crypto…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Magellan Health Announces Market Leadership Appointments
Tech GIANT’s Plans to Revolutionize Crypto…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Magellan Health Svcs
Magellan Health Stock Soars on 4Q Earnings
See More Headlines
Receive MGLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Magellan Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/05/2021
Today
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospitals
Sub-Industry
Managed Health Care
Current Symbol
NASDAQ:MGLN
CUSIP
55907920
Employees
9,000
Year Founded
N/A

Profitability

Net Income
$382.33 million
Pretax Margin
-0.08%

Debt

Sales & Book Value

Annual Sales
$4.58 billion
Cash Flow
$5.57 per share
Book Value
$73.03 per share

Miscellaneous

Free Float
22,619,000
Market Cap
$2.50 billion
Optionable
Optionable
Beta
1.03
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Kenneth J. Fasola
    Chief Executive Officer & Director
  • James E. Murray
    President & Chief Operating Officer
  • David Patrick Bourdon
    Chief Financial Officer
  • Caroline Carney
    Chief Medical Officer
  • Jeffrey N. West
    Principal Accounting Officer, SVP & Controller

MGLN Stock Analysis - Frequently Asked Questions

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) announced its quarterly earnings results on Friday, November, 5th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.37 by $0.34. The company earned $1.25 billion during the quarter, compared to analysts' expectations of $1.21 billion. Magellan Health had a net margin of 6.26% and a trailing twelve-month return on equity of 1.81%. Magellan Health's revenue was up 7.2% on a year-over-year basis. During the same period last year, the firm earned $0.08 earnings per share.

What is Kenneth J. Fasola's approval rating as Magellan Health's CEO?

31 employees have rated Magellan Health Chief Executive Officer Kenneth J. Fasola on Glassdoor.com. Kenneth J. Fasola has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer (ET), General Motors (GM), NVIDIA (NVDA), Boeing (BA), Netflix (NFLX), UnitedHealth Group (UNH), Broadcom (AVGO), Mastercard (MA), Ford Motor (F) and Overstock.com (OSTK).

This page (NASDAQ:MGLN) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners